Semaglutide‐induced weight loss improves mitochondrial energy efficiency in skeletal muscle
Obesity · 2025
DOI: 10.1002/oby.24274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, 2025. Verfasst von Ran Hee Choi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes & Metabolism Research Center, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Glucagon-Like Peptides, Weight Loss, Muscle, Skeletal, Energy Metabolism. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Objective
Glucagon‐like peptide‐1 receptor agonists (e.g., semaglutide) potently induce weight loss, thereby reducing obesity‐related complications. However, weight regain occurs when treatment is discontinued. An increase in skeletal muscle oxidative phosphorylation (OXPHOS) efficiency upon diet‐mediated weight loss has been described, which may contribute to reduced systemic energy expenditure and weight regain. We set out to determine the unknown effect of semaglutide on muscle OXPHOS efficiency.
Methods
C57BL/6J mice were fed a high‐fat diet for 12 weeks before receiving semaglutide or vehicle for 1 or 3 weeks. The rates of ATP production and oxygen (O 2 ) consumption were measured via high‐resolution respirometry and fluorometry to determine OXPHOS efficiency in muscle at these two time points.
Results
Semaglutide treatment led to significant reductions in fat and lean mass. Semaglutide improved skeletal muscle OXPHOS efficiency, measured as ATP produced per O 2 consumed in permeabilized muscle fibers. Mitochondrial proteomic analysis revealed changes restricted to two proteins linked to complex III assembly (LYRM7 and TTC19; p < 0.05 without multiple corrections) without substantial changes in the abundance of OXPHOS subunits.
Conclusions
These data indicate that weight loss with semaglutide treatment increases skeletal muscle mitochondrial efficiency. Future studies could test whether it contributes to weight regain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Diabetes & Metabolism Research Center, University of Utah, Salt Lake City, Utah, USA.
- Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.
- Research Institute of Sport Science, Nippon Sport Science University, Setagaya, Japan.
- Mass Spectrometry and Proteomics Core, University of Utah, Salt Lake City, Utah, USA.
- Electron Microscopy Core Facility, University of Utah, Salt Lake City, Utah, USA.
- Department of Cancer Biology, Comprehensive Cancer Center of Wake Forest Baptist Health, Winston-Salem, North Carolina, USA.
ORCID-Profile: Ran Hee Choi, Amandine Chaix, Katsuhiko Funai
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
- Japan Society for the Promotion of Science
- NIA NIH HHS
- NCI NIH HHS
- National Institute of General Medical Sciences
- National Institute on Aging
- National Cancer Institute
Zitieren
APA
Choi, R. H., Karasawa, T., Meza, C. A., Maschek, J. A., Manuel, A. M., Nikolova, L. S., Fisher-Wellman, K. H., Cox, J. E., Chaix, A., & Funai, K. (2025). Semaglutide‐induced weight loss improves mitochondrial energy efficiency in skeletal muscle. Obesity. https://doi.org/10.1002/oby.24274
Vancouver
Choi RH, Karasawa T, Meza CA, Maschek JA, Manuel AM, Nikolova LS, et al. Semaglutide‐induced weight loss improves mitochondrial energy efficiency in skeletal muscle. Obesity. 2025. doi:10.1002/oby.24274
BibTeX
@article{Choi2025,
author = {Choi, Ran Hee and Karasawa, Takuya and Meza, Cesar A and Maschek, J Alan and Manuel, Allison M and Nikolova, Linda S and Fisher-Wellman, Kelsey H and Cox, James E and Chaix, Amandine and Funai, Katsuhiko},
title = {Semaglutide‐induced weight loss improves mitochondrial energy efficiency in skeletal muscle},
journal = {Obesity},
year = {2025},
doi = {10.1002/oby.24274}
}
EUVIMED